Photo Credit: Getty Images
A deeply personal family health discovery has become part of the story surrounding Alix Earle's new Netflix series, Earle Meets World, after the social media personality and her sister, Ashtin Earle, learned they carry a BRCA2 genetic mutation.
The sisters decided to undergo genetic testing following their mother Alisa Maniaci's diagnosis with breast cancer. What began as an attempt to understand their family's health history quickly became an emotional moment captured by cameras for the series.
During the episode, the family met with genetic counselor Pankti Doshi, who explained the process before revealing the results. Both sisters tested positive for the genetic change in BRCA2.
The news prompted an emotional reaction from Alisa, who appeared to blame herself for potentially passing the genetic change to her daughters. Her daughters immediately reassured her, turning what could have been an overwhelming moment into one of family support.
Alix, 25, told her sister that knowing their genetic status meant they could face the future together. Rather than viewing the results solely through fear, she described the opportunity to know as a privilege because it allowed the sisters to look after each other.
The moment also illustrated how a family can navigate difficult medical information while under the unusual circumstances of a reality television production.
Speaking at the premiere of Earle Meets World, Alix said the cameras became secondary as the family focused on supporting one another. She explained that the circumstances were unfolding naturally and that the family wanted audiences to see the experience as it happened.
BRCA2 is a gene involved in repairing damaged DNA. Certain inherited changes in BRCA2 are associated with increased risks of several cancers, which is why genetic counseling and appropriate medical follow up can be important for people who test positive.
For the Earle family, the discovery has brought a new awareness of their health and future. Alisa reassured her daughters that the results did not mean something immediately had to happen to them and emphasized the importance of remaining strong and proactive.
The sisters' decision to publicly share the experience also highlights the increasingly visible role genetic testing plays in conversations about hereditary cancer risk. Testing can provide information that helps individuals and healthcare professionals make informed decisions about monitoring and risk management.
Rather than presenting the diagnosis as an ending, the family has framed the discovery as knowledge that gives them an opportunity to be prepared.
For viewers, the episode offers a glimpse beyond the glamour and social media presence associated with the Earle family, revealing a more vulnerable reality in which health, uncertainty and family solidarity take center stage.
